BIOMAT Database Logo BIOMAT Database Logo

[Cell-free Pseudomonas vaccine. II. Isolation and immunological properties of protective antigens of Pseudomonas aeruginosa]. 1981

E S Stanislavskiĭ, and N A Palkina, and V F Bulk, and M I Zhvanetskaia, and L V Chekan

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D002458 Cell Fractionation Techniques to partition various components of the cell into SUBCELLULAR FRACTIONS. Cell Fractionations,Fractionation, Cell,Fractionations, Cell
D002850 Chromatography, Gel Chromatography on non-ionic gels without regard to the mechanism of solute discrimination. Chromatography, Exclusion,Chromatography, Gel Permeation,Chromatography, Molecular Sieve,Gel Filtration,Gel Filtration Chromatography,Chromatography, Size Exclusion,Exclusion Chromatography,Gel Chromatography,Gel Permeation Chromatography,Molecular Sieve Chromatography,Chromatography, Gel Filtration,Exclusion Chromatography, Size,Filtration Chromatography, Gel,Filtration, Gel,Sieve Chromatography, Molecular,Size Exclusion Chromatography
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial

Related Publications

E S Stanislavskiĭ, and N A Palkina, and V F Bulk, and M I Zhvanetskaia, and L V Chekan
[Cell-free Pseudomonas vaccine. III. Immunochemical analysis of purified Pseudomonas aeruginosa protein antigens and protective properties of antisera against these antigens].
February 1983, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
E S Stanislavskiĭ, and N A Palkina, and V F Bulk, and M I Zhvanetskaia, and L V Chekan
[Cell-free pseudomonas vaccine. I. Enzyme properties and virulence of strains of P. aeruginosa; protective activity of their water-soluble antigens].
August 1980, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
E S Stanislavskiĭ, and N A Palkina, and V F Bulk, and M I Zhvanetskaia, and L V Chekan
[Protective protein antigens of Pseudomonas aeruginosa].
November 1985, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
E S Stanislavskiĭ, and N A Palkina, and V F Bulk, and M I Zhvanetskaia, and L V Chekan
Clinico-immunological trials of Pseudomonas aeruginosa vaccine.
July 1991, Vaccine,
E S Stanislavskiĭ, and N A Palkina, and V F Bulk, and M I Zhvanetskaia, and L V Chekan
Serological properties of Pseudomonas aeruginosa. II. Type-specific thermolabile (flagellar) antigens.
January 1970, Acta microbiologica Academiae Scientiarum Hungaricae,
E S Stanislavskiĭ, and N A Palkina, and V F Bulk, and M I Zhvanetskaia, and L V Chekan
Immunological evaluation of OMP-F of native Iranian Pseudomonas aeruginosa as a protective vaccine.
October 2012, Journal of infection in developing countries,
E S Stanislavskiĭ, and N A Palkina, and V F Bulk, and M I Zhvanetskaia, and L V Chekan
[Isolation and study of the properties of a polyvalent corpuscular Pseudomonas aeruginosa vaccine. An evaluation of the biological properties of a polyvalent corpuscular Pseudomonas aeruginosa vaccine].
July 1985, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
E S Stanislavskiĭ, and N A Palkina, and V F Bulk, and M I Zhvanetskaia, and L V Chekan
[The protective properties of Pseudomonas aeruginosa anatoxin].
January 1985, Mikrobiologicheskii zhurnal,
E S Stanislavskiĭ, and N A Palkina, and V F Bulk, and M I Zhvanetskaia, and L V Chekan
[Effect of the protective properties of antisera and immunoglobulin to antigens of Pseudomonas aeruginosa slime].
October 1980, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
E S Stanislavskiĭ, and N A Palkina, and V F Bulk, and M I Zhvanetskaia, and L V Chekan
Killed but metabolically active Pseudomonas aeruginosa-based vaccine induces protective humoral- and cell-mediated immunity against Pseudomonas aeruginosa pulmonary infections.
March 2018, Vaccine,
Copied contents to your clipboard!